Default object view. Click to create a custom template, Node ID: 111765, Object ID: 66796

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the Eu...

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

No relation

Yes

No relation

No

30/05/2015 10:44 am

No